Relationship between vitamin D and post-transplant diabetes mellitus in kidney transplant recipients

Table 3 Patient outcomes and lab parameters during follow-up

	Total	PTDM	Controls	P value
Number of cases	72	32	40
Duration of follow-up (weeks)	46.9 ± 4.8	47.9 ± 0.2	46.1 ± 6.3	0.116
Acute rejection	12 (16.6)	3 (9.3)	9 (22.5)	0.138
MP pulse given	10 (13.8)	2 (6.2)	8 (20.0)	0.094
CMV infection	6 (8.3)	4 (12.5)	2 (5.0)	0.253
HCV infection	13 (18.0)	6 (18.7)	7 (21.0)	0.891
Serum vitamin D levels
> 30 ng/mL (sufficient)	10 (13.8)	2 (6.2)	8 (20.0)	0.007
20-30 ng/mL (insufficient)	18 (25.0)	4 (12.5)	14 (43.7)
< 20 ng/mL (deficient)	44 (61.0)	26 (81.2)	18 (56.2)
Serum calcium levels (mg/dL)	8.8 ± 0.08	9.0 ± 0.70	8.7 ± 0.60	0.080
Serum phosphate levels (mg/dL)	2.9 ± 0.7	3.1 ± 0.9	2.8 ± 0.5	0.231
Proteinuria(g/dL), median (minimum-maximum)	0.3 (0.2-0.4)	0.5 (0.3-0.7)	0.2 (0.2-0.3)	0.023
Serum creatinine (mg/dL), median (minimum-maximum)	1.2 (0.6-7.0)	1.3 (1.0-1.5)	1.1 (1.0-1.7)	0.367

Data are presented as n (%) or mean ± SD. PTDM: Post-transplant diabetes mellitus; MP: Methylprednisolone; CMV: Cytomegalovirus; HCV: Hepatitis C virus.